1 - 25 of
141
results
for author:"Fujita K."
in Literature Citations
| A Functional Polymorphism in IL-18 is Associated with Severity of Bronchial Asthma. Harada M., Obara K., Hirota T., Yoshimoto T., Hitomi Y., Sakashita M., Doi S., Miyatake A., Fujita K., Enomoto T. et al. Am. J. Respir. Crit. Care Med. 0:0-0(2009) · Mapped (4) |
| DNA vector-based RNA interference in cell lines derived from Bombyx mori. Fujita K., Sagisaka A., Tomimoto K., Ishibashi J., Imanishi S., Yamakawa M., Tanaka H. Biosci. Biotechnol. Biochem. 73:2026-2031(2009) · UniProtKB (1) |
| p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Fujita K., Mondal A.M., Horikawa I., Nguyen G.H., Kumamoto K., Sohn J.J., Bowman E.D., Mathe E.A., Schetter A.J., Pine S.R. et al. Nat. Cell Biol. 11:1135-1142(2009) · Mapped (31) |
| Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease. Yoneda M., Hotta K., Nozaki Y., Endo H., Tomeno W., Watanabe S., Hosono K., Mawatari H., Iida H., Fujita K. et al. Hepatol. Res. 39:963-971(2009) · Mapped (3) |
| Identification of Cystatin SN as a novel tumor marker for colorectal cancer. Yoneda K., Iida H., Endo H., Hosono K., Akiyama T., Takahashi H., Inamori M., Abe Y., Yoneda M., Fujita K. et al. Int. J. Oncol. 35:33-40(2009) · Mapped (1) |
| ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression. Kumamoto K., Fujita K., Kurotani R., Saito M., Unoki M., Hagiwara N., Shiga H., Bowman E.D., Yanaihara N., Okamura S. et al. Int. J. Cancer 125:1306-1315(2009) · Mapped (3) |
| Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease. Yoneda M., Hotta K., Nozaki Y., Endo H., Uchiyama T., Mawatari H., Iida H., Kato S., Fujita K., Takahashi H. et al. Liver Int. 29:1078-1085(2009) · Mapped (4) |
| The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator. Hibuse T., Maeda N., Nakatsuji H., Tochino Y., Fujita K., Kihara S., Funahashi T., Shimomura I. Cardiovasc. Res. 83:34-41(2009) · Mapped (2) |
| Serum Ferritin Is a Clinical Biomarker in Japanese Patients with Nonalcoholic Steatohepatitis (NASH) Independent of HFE Gene Mutation. Yoneda M., Nozaki Y., Endo H., Mawatari H., Iida H., Fujita K., Yoneda K., Takahashi H., Kirikoshi H., Inamori M. et al. Dig. Dis. Sci. 0:0-0(2009) · Mapped (20) |
| Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers. Takanashi M., Oikawa K., Fujita K., Kudo M., Kinoshita M., Kuroda M. Am. J. Pathol. 174:309-316(2009) · Mapped (3) |
| Inhibition of peroxisome proliferator-activated receptor gamma activity suppresses pancreatic cancer cell motility. Nakajima A., Tomimoto A., Fujita K., Sugiyama M., Takahashi H., Ikeda I., Hosono K., Endo H., Yoneda K., Iida H. et al. Cancer Sci. 99:1892-1900(2008) · Mapped (10) |
| Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH). Yoneda M., Uchiyama T., Kato S., Endo H., Fujita K., Yoneda K., Mawatari H., Iida H., Takahashi H., Kirikoshi H. et al. BMC Gastroenterol 8:53-53(2008) · Mapped (1) |
| Endoglin (CD105) as a urinary and serum marker of prostate cancer. Fujita K., Ewing C.M., Chan D.Y., Mangold L.A., Partin A.W., Isaacs W.B., Pavlovich C.P. Int. J. Cancer 124:664-669(2009) · Mapped (10) |
| Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI). Fujita K., Nagashima F., Yamamoto W., Endo H., Sunakawa Y., Yamashita K., Ishida H., Mizuno K., Matsunaga M., Araki K. et al. Biol. Pharm. Bull. 31:2137-2142(2008) · Mapped (3) |
| Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy. Akiyama Y., Fujita K., Nagashima F., Yamamoto W., Endo H., Sunakawa Y., Yamashita K., Ishida H., Mizuno K., Araki K. et al. Ann. Oncol. 19:2089-2090(2008) · Mapped (6) |
| Involvement of reduced folate carrier 1 in the inner blood-retinal barrier transport of methyltetrahydrofolate. Hosoya K., Fujita K., Tachikawa M. Drug Metab. Pharmacokinet. 23:285-292(2008) · Mapped (1) |
| Expression pattern of sonic hedgehog and effect of topical mitomycin C on its expression in human ocular surface neoplasms. Fujita K., Miyamoto T., Okada Y., Ishikawa N., Saika S. Jpn. J. Ophthalmol. 52:190-194(2008) · Mapped (1) |
| Immunohistochemical identification of messenger RNA-related proteins in basophilic inclusions of adult-onset atypical motor neuron disease. Fujita K., Ito H., Nakano S., Kinoshita Y., Wate R., Kusaka H. Acta Neuropathol. 116:439-445(2008) · Mapped (13) |
| Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Tamba S., Nishizawa H., Funahashi T., Okauchi Y., Ogawa T., Noguchi M., Fujita K., Ryo M., Kihara S., Iwahashi H. et al. Intern. Med. 47:1175-1180(2008) · Mapped (3) |
| Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD). Yoneda M., Hotta K., Nozaki Y., Endo H., Uchiyama T., Mawatari H., Iida H., Kato S., Hosono K., Fujita K. et al. BMC Gastroenterol 8:27-27(2008) · Mapped (5) |
| Serum C-reactive protein even at very low (<1.0 mg/l) concentration is associated with physical performance in a community-based elderly population aged 70 years and over. Niu K., Hozawa A., Guo H., Kuriyama S., Ebihara S., Yang G., Ohmori-Matsuda K., Nakaya N., Takahashi H., Fujita K. et al. Gerontology 54:260-267(2008) · Mapped (3) |
| Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Kumamoto K., Spillare E.A., Fujita K., Horikawa I., Yamashita T., Appella E., Nagashima M., Takenoshita S., Yokota J., Harris C.C. Cancer Res. 68:3193-3203(2008) · Mapped (34) |
| CARP-2 is an endosome-associated ubiquitin ligase for RIP and regulates TNF-induced NF-kappaB activation. Liao W., Xiao Q., Tchikov V., Fujita K., Yang W., Wincovitch S., Garfield S., Conze D., El-Deiry W.S., Schutze S. et al. Curr. Biol. 18:641-649(2008) · Mapped (1) |
| Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms. Kobayashi N., Inamori M., Fujita K., Fujisawa T., Fujisawa N., Takahashi H., Yoneda M., Abe Y., Kawamura H., Shimamura T. et al. J Hepatobiliary Pancreat Surg 15:169-177(2008) · Mapped (8) |
| CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1. Fujita K., Yamamoto W., Endo S., Endo H., Nagashima F., Ichikawa W., Tanaka R., Miya T., Araki K., Kodama K. et al. Cancer Sci. 99:1049-1054(2008) · Mapped (2) |
